The management of the obese diabetic patient

Keyphrases

• Obese Diabetic Patients 100%
• Glycemic Control 44%
• Weight Gain 33%
• Insulin 22%
• Insulin Resistance 22%
• Oral Agents 22%
• High Dose 11%
• Diabetes 11%
• Lifestyle Modification 11%
• United States 11%
• Pharmacological Therapy 11%
• Type 2 Diabetes Mellitus (T2DM) 11%
• Weight Control 11%
• Weight Reduction 11%
• Orlistat 11%
• Sibutramine 11%
• Diabetic 11%
• Obese Patients 11%
• Diabetic Patients 11%
• Monotherapy 11%
• Bariatric Surgery 11%
• Vascular Complications 11%
• Effective Treatment 11%
• Exogenous Insulin 11%
• Morbid Obesity 11%
• Reducing Agent 11%
• Termbase 11%
• Oral Hypoglycemic Agents 11%
• Obesity Prevalence 11%
• Gastric Bypass 11%
• Massive Weight Loss 11%
• Diabetes Prevalence 11%
• Pharmacologic Agents 11%
• Vicious Cycle 11%
• Glycemia 11%
• Insulin Therapy 11%
• Cell Dysfunction 11%
• Avail 11%
• Intensive Glycemic Control 11%
• NHANES III 11%
• Hypoglycemic Therapy 11%
• Kumamoto 11%
• Weight Reducing 11%
• Explode 11%
• UK Prospective Diabetes Study (UKPDS) 11%

Nursing and Health Professions

• Diabetic Obesity 100%
• Diabetes Mellitus 22%
• Insulin Resistance 22%
• Drug Megadose 11%
• Lifestyle Modification 11%
• Prevalence 11%
• Disease 11%
• Monotherapy 11%
• Glucose Blood Level 11%
• Non Insulin Dependent Diabetes Mellitus 11%
• Gastric Bypass Surgery 11%
• Antidiabetic Agent 11%
• Insulin Treatment 11%
• Body Weight Loss 11%
• Bariatric Surgery 11%
• National Health and Nutrition Examination Survey 11%
• Weight Control 11%
• Reducing Agent 11%
• Tetrahydrolipstatin 11%
• Sibutramine 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetic Obesity 100%
• Diabetes Mellitus 22%
• Insulin Resistance 22%
• Disease 11%
• Prevalence 11%
• Monotherapy 11%
• Tetrahydrolipstatin 11%
• Sibutramine 11%
• Reducing Agent 11%
• Antidiabetic Agent 11%
• Non Insulin Dependent Diabetes Mellitus 11%